And the preferred have won a court room ruling for the B shares. The C shares have a strong chance on appeal, due to the realization that C shareholders were not given an opportunity to provide "written consents" or vote at a special meeting. Trial date is set for October on the appeals.
Meanwhile, none of the old management is still in place. And new management has accumulated excess proceeds from sales of MSRs to fund securitization of over $700 million in Non-QM. So, the picture of this stock is set to change.
FEATURED Omega Laboratories Reports Completion of Method Validation with Cannabix Technologies Inc. for Marijuana Breath Detection • Mar 18, 2025 8:36 AM
UAV Corp. to Present Critical Inflation Test in 30 Days, Paving the Way to Secure Over $525 Million in DART Series Sales Contracts • UMAV • Mar 14, 2025 1:00 PM
Fifty 1 Labs, Inc. Completes Name and Symbol Change, Advances Toward Regaining 15c211 Compliance • FITY • Mar 14, 2025 10:30 AM
WIN-LIGHT GLOBAL FILES SEC SCHEDULE 13G DISCLOSING 1.96M SHARES OF PASSIVE INSTITUTIONAL INVESTOR OWNERSHIP • CNTM • Mar 14, 2025 7:13 AM
The Crypto Company Expands Leadership Team With Experienced Financial and Blockchain Professionals • CRCW • Mar 13, 2025 9:23 AM
ConnectM Announces $10 Million Share Repurchase Program • CNTM • Mar 13, 2025 9:13 AM